Latest News for: muscular dystrophy

Edit

Youth with muscular dystrophy set to be co-op sr inspector

The Times of India 10 Aug 2025
Battling muscular dystrophy since his school days, the young boy has now cleared Group 2A combined civil services exam mains Feb 2025, and is set to join the cooperative department as a senior inspector.
Edit

Limb Girdle Muscular Dystrophy Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight ...

GetNews 06 Aug 2025
Limb Girdle Muscular Dystrophy Emerging therapies such as - CAT-1004, SRP-9005, Stryka 516s, MYO 102, SRP-9003, ATYR1940, BBP-418, and others are expected to have a significant impact on the Limb Girdle Muscular Dystrophy market in the coming years.
Edit

Tennessee boy channels 'The Flash' in race to cure Duchenne muscular dystrophy

The Tennessean 05 Aug 2025
12-year-old Deklan Locke, who has Duchenne muscular dystrophy, uses a power wheelchair and raises awareness about the disease.Duchenne muscular dystrophy is a rare genetic disorder that causes muscle ...
Edit

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)

Nasdaq Globe Newswire 04 Aug 2025
- Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - �� ... .
Edit

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) (Form 8-K) (Dyne Therapeutics Inc)

Public Technologies 04 Aug 2025
The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.
Edit

Hansa Biopharma announces supportive data from treatment with imlifidase prior to the administration of gene therapy for Duchenne muscular dystrophy (Hansa Biopharma AB)

Public Technologies 01 Aug 2025
2025-08-01 21.15.00 CEST Hansa Biopharma AB - Inside information Hansa Biopharma announces supportive data from treatment with imlifidase prior to the administration of gene therapy for Duchenne muscular dystrophy.
Edit

Family to take on Lake District triathlon challenge for son with muscular dystrophy

Yahoo Daily News 30 Jul 2025
Muscular Dystrophy UK) Sam Taylor, who created the challenge, is joined by his wife Sue, 47, and daughter Beth, 17. They are taking part in support of his eldest son Will, 16, who lives with Duchenne muscular dystrophy ... Muscular Dystrophy UK) She said.
Edit

MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy (MetrioPharm AG)

Public Technologies 29 Jul 2025
2025-Jul-29 edicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD) ... DMD is the most common form of muscular dystrophy.
Edit

Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances ...

Nasdaq Globe Newswire 28 Jul 2025
The Duchenne muscular dystrophy market is witnessing steady growth driven by advancements in gene therapies, exon-skipping drugs, and corticosteroid alternatives.
Edit

Fundraiser to benefit local twins with muscular dystrophy

Gettysburg Times 27 Jul 2025
A sweet tradition will return to Arendtsville on Saturday, Aug. 3, as McDannell’s Fruit Farm and Market hosts its annual Peach Sundae event to raise money for a local family ....
Edit

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU

Nasdaq Globe Newswire 25 Jul 2025
... for ambulatory individuals aged three to seven years with Duchenne muscular dystrophy (DMD).
×